The case for treating mild hyperthyroidism

Article

Ob/gyns are increasingly being called upon to manage subclinical thyroid disease. In this concluding article of a two-part series, two experts clarify the controversy over when to treat mild hyperthyroidism. Do treat a mildly overactive thyroid in elderly patients, they say, because low bone density and cardiac abnormalities can do substantial harm.

Few colleagues would argue over how to diagnose or treat overt thyroid disease. But it's a different story for more subtle "mild" thyroid disease-a term now commonly preferred to "subclinical."1 A key point from our article on mild hypothyroidism ("When should you screen for and treat mild hypothyroidism?" Contemporary OB/GYN, January 2006) http://www.contemporaryobgyn.net/obgyn/article/articleDetail.jsp?id=283482 holds true for mild hyperthyroidism: Diagnosing and deciding when to treat mild thyroid disease is still complicated by controversies over the reference values of the thyroid function tests upon which we base the diagnosis of disease and many clinical decisions. Once again our goal here is to discuss factors affecting your decision on when to treat mild hyperthyroidism and to give causes, guidelines, and treatment options.

Measuring 'normal' thyroid function

Also as discussed in Part I, when individuals with risk factors for autoimmune thyroid disease (especially thyroid antibodies), were excluded from a large control population, the average TSH was ~1.5 μU/mL.2 The lower limit for TSH in this group, and in other reports, was ~0.4 μU/mL. [Hence, mild hyperthyroidism may be defined by a TSH below 0.4 μU/mL with normal thyroid hormone levels (free T4 and T3). However, patients with mild hyperthyroidism are often divided further into two subgroups, one with a TSH of 0.1 to 0.4, and a second group with TSH under 0.1. With third-generation TSH assays, TSH may be reported at levels below 0.1, and this clearly indicates hyperthyroidism.]

Related Videos
Understanding combined oral contraceptives and breast cancer risk | Image Credit: health.ucdavis.edu
Why doxycycline PEP lacks clinical data for STI prevention in women
The importance of nipocalimab’s FTD against FNAIT | Image Credit:  linkedin.com
Enhancing cervical cancer management with dual stain | Image Credit: linkedin.com
Fertility treatment challenges for Muslim women during fasting holidays | Image Credit: rmanetwork.com
Understanding the impact of STIs on young adults | Image Credit: providers.ucsd.edu.
CDC estimates of maternal mortality found overestimated | Image Credit: rwjms.rutgers.edu.
Study unveils maternal mortality tracking trends | Image Credit: obhg.com
How Harmonia Healthcare is revolutionizing hyperemesis gravidarum care | Image Credit: hyperemesis.org
Unveiling gender disparities in medicine | Image Credit:  findcare.ahn.org.
Related Content
© 2024 MJH Life Sciences

All rights reserved.